A warning letter has been issued to ExThera Medical Corporation for distributing its product to a hospital for compassionate use (CU) without premarket approval.
In the communication, penned by the US Food and Drug Administration (FDA) on February 6, 2026, the California-based medical device maker was also put on notice
According to